1. Overcoming Irinotecan Resistance by Targeting Its Downstream Signaling Pathways in Colon Cancer
   Shashank Saurav et al, 2024, Cancers CrossRef
2. Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
   Nilesh Kumar Sharma et al, 2024, Cancers CrossRef
3. Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy
   Jhen-Yu Chen et al, 2024, Cancer Immunology, Immunotherapy CrossRef